Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04095546

Epigenetic Changes in Psychotherapy of Adolescents With Borderline Personality Pathology

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
14 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The link between epigenetic changes as an effect of psychotherapy has been investigated recently. Genes investigated in these studies were brain-derived neurotrophic factor (BDNF), NR3C1, FKBP51, MAOA and GLUT1. Change in methylation of these genes could be a biomolecular mechanism of psychotherapy induced changes. This study project aims at providing evidence for a biological mechanism of personality disorder interventions in adolescence by investigating the link between epigenetic changes as an effect of psychotherapy. It investigates the correlation between changes in the methylation of the FKBP5 gene and psychotherapy induced changes in symptoms and functioning.

Conditions

Interventions

TypeNameDescription
OTHERroutine psychotherapy for Borderline Personality Disorder (BPD)Routine psychotherapy as treatment for patients with Borderline Personality Disorder

Timeline

Start date
2022-04-01
Primary completion
2024-02-01
Completion
2024-12-01
First posted
2019-09-19
Last updated
2022-09-13

Source: ClinicalTrials.gov record NCT04095546. Inclusion in this directory is not an endorsement.